Zhao et al. [15] reported down-regulation of HLA class I genes (which comprise HLA-A, HLA-B, or HLA-C) on CD4(+) and on CD8(+) T lymphocytes in breast cancer patients when as compared with healthy controls. This evidence concerns the gene HLA-B and breast carcinoma.